Bunka Christopher

Bunka Christopher is listed in filings as Director at Lexaria Bioscience Corp.. This profile follows SEC Form 4 activity through Mar 18, 2026, including purchase activity. Recent filings connect the profile to Lexaria Bioscience Corp. (LEXX). The current snapshot covers public activity from Jan 10, 2025 to Mar 18, 2026. Reported amounts are shown as $10.9K to $11.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.